Jeena Sikho Lifecare Limited — Investor Meet, 14-08-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Jeena Sikho Lifecare reported Q1 FY27 revenue of 224 Cr (+29% YoY), EBITDA of 92 Cr (41% margin), and PAT of 65 Cr (28% margin). Product business surged 47% YoY. Management is laser-focused on 'prevention-first' healthcare, targeting 3,000 Cr turnover & 7,000-10,000 beds within 3-5 years, alongside 30% YoY growth. New ultra-luxury wellness centers like the upcoming Manali facility are set to drive high margins. A strategic shift to cash-rich private business (reducing government work) and ongoing tech investments underpin their long-term vision, maintaining confidence in 40%+ EBITDA and 27-30% net profit.